Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > I'll take 15% all day!

<< Previous

Bullboard Posts

Next >>

Post by Yellowknifer69on Feb 16, 2021 3:55pm

284 Views

Post# 32576392

I'll take 15% all day!

Hello and good afternoon ATE Longs:

very nice steady movement today - I love it. I will take 15% everyday from here on in!

Interesting to read all the posts and so thanks to all for sharing - even Dusty! Although a bit of a head scratcher to be sure when you sell at $6.65 and looking to finish the day at $6.80. It must be hard to be so smart and leave profits on the table!

I am curious to learn if Dan puts out any further news this week? But it has been a strong run.

Staying long - especially if analysts are correct and we are heading to $15 shortly.

Yellowknifer

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (June 28, 2024)